Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A pocket-sized coach for insulin users? app aims to boost self-care in type 2 diabetes

NCT ID NCT06060743

Disease control Sponsor: Ege University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study tests a newly developed mobile app designed for adults with type 2 diabetes who are starting insulin for the first time. The app aims to improve how people perceive insulin use and how well they manage their own care. Over one month, participants will use the app and have their insulin knowledge, attitudes, and self-management skills assessed at several points. The goal is to see if this digital tool can make insulin therapy easier to handle and more effective in daily life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A mobile application developed to support insulin use and self-management in type 2 diabetes
What this could lead to
If effective, this app could help people with type 2 diabetes feel more confident and skilled at managing insulin, potentially improving their daily diabetes care.
What could go wrong
This is a small, early-stage study. The app's benefits may not be confirmed, and results may not apply to all people with diabetes. There are no major physical risks, but the app's usefulness depends on user engagement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

88 people

The number who actually took part.

Started

Jan 2024

Finished

May 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years and over, * Aware and communicative, * Those diagnosed with Type 2 DM and using insulin for the first time * Able to administer insulin on his own, * Able to use Android based phone, * Having a digital literacy scale score above 17, * Agreeing to participate in the research Exclusion Criteria: * Under 18 years of age, * Having vision problems, * Do not have an Android phone, * Unconscious and unable to communicate, * Not having sufficient motor skills, * Those who did not agree to participate in the research

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes treated with insulin are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 2 diabetes treated with insulin

Contacts and locations

Locations

  • Ege University

    Izmir, Bornova, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.